Farallon Capital Management’s Pardes Biosciences PRDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,000,000
Closed -$10M – 325
2021
Q3
$10M Hold
1,000,000
– – 0.05% 130
2021
Q2
$10M Hold
1,000,000
– – 0.04% 126
2021
Q1
$10M Buy
+1,000,000
New +$10.3M 0.05% 141

Other funds holding PRDS

Farallon Capital Management's PRDS Position: Q4 2021 in Review

Farallon Capital Management sold out of Pardes Biosciences (PRDS) in Q4 2021, closing a stake of 1,000,000 shares — an estimated $10M sold.

Farallon Capital Management first reported a position in PRDS in Q1 2021 and held it in 3 quarters. The position peaked at $10M in Q2 2021. 41 funds tracked by Wall St. Rank hold PRDS as of Q4 2021.

  • Farallon Capital Management reported no remaining Pardes Biosciences position as of Q4 2021 after selling out during the quarter.
  • Farallon Capital Management sold 1,000,000 Pardes Biosciences shares in Q4 2021, an estimated $10M.
  • Farallon Capital Management first reported a position in Pardes Biosciences in Q1 2021 and held it in 3 quarters.
  • Farallon Capital Management's Pardes Biosciences position peaked at $10M in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Pardes Biosciences as of Q4 2021.

Based on Farallon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.